MedTrace Logo

Screening for Lysosomal Acid Lipase Deficiency

NCT02926872 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2017-06-16

No results posted yet for this study

Summary

The primary outcome of this study is the development of a clinical profile of pediatric patients with LAL-D, which will enable the Sponsor to provide more focused guidance to the medical community as to which pediatric patients should be tested for LAL-D.

Conditions

  • Lysosomal Acid Lipase Deficiency

Interventions

OTHER

There is no intervention in the study

Sponsors & Collaborators

  • Alexion Pharmaceuticals, Inc.

    lead INDUSTRY

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-06-05
Completion
2017-06-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02926872 on ClinicalTrials.gov